The effects of rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, on markers of endothelial cell activation, C-reactive protein, and fibrinogen levels in non-diabetic coronary artery disease patients

By Sidhu J.S.   Cowan D.   Kaski J.-C.  

Journal of the American College of Cardiology, Vol. 42, Iss. 10, 2003-11 ,pp. : 1757-1763

Elsevier

Access to resources Recommend Favorite

The Prevalence of Endothelial Dysfunction in Patients With and Without Coronary Artery Disease

By  

Clinical Cardiology, Vol. 33, Iss. 12, 2010-12 ,pp. : 746-752

John Wiley & Sons Inc

Access to resources Recommend Favorite

Coagulation status in coronary artery disease patients with type II diabetes mellitus compared with non-diabetic coronary artery disease patients using the PFA-100® and ROTEM®

By Feuring M.   Wehling M.   Burkhardt H.   Schultz A.  

Platelets, Vol. 21, Iss. 8, 2010-12 ,pp. : 616-622

Informa Healthcare

Access to resources Recommend Favorite

Erectile Dysfunction and Coronary Artery Disease in Patients with Diabetes

By  

Current Diabetes Reviews, Vol. 7, Iss. 2, 2011-01 ,pp. : 143-147

Bentham Science Publishers

Access to resources Recommend Favorite

Usefulness of attenuated heart rate recovery immediately after exercise to predict endothelial dysfunction in patients with suspected coronary artery disease

By Huang P.-H.   Leu H.-B.   Chen J.-W.   Cheng C.-M.   Huang C.-Y.   Tuan T.-C.   Ding P.Y.-A.   Lin S.-J.  

The American Journal of Cardiology, Vol. 93, Iss. 1, 2004-01 ,pp. : 10-13

Elsevier

Access to resources Recommend Favorite